» Articles » PMID: 9345028

Thrombopoietin is Synthesized by Bone Marrow Stromal Cells

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 1997 Nov 14
PMID 9345028
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously characterized stromal progenitor cells contained in fetal bone marrow by fluorescence-activated cell sorting (FACS) using the differential expression of CD34, CD38, and HLA-DR, and found that a small number were contained within the CD34(+) cell fraction. In the present study, the frequency of stromal progenitors in both the CD34+ and CD34- subpopulations from samples of fetal and adult bone marrow was approximately one in 5,000 of the mononuclear cell fraction. Using multiparameter single-cell sorting, one in 20 fetal bone marrow cells with the CD34+, CD38-, HLA-DR-, CDw90+ phenotype were clonogenic stromal progenitors, whereas greater than one in five single cells with the CD34-, CD38-, HLA-DR-, CDw90+ phenotype formed stromal cultures. We found that cultures initiated by hematopoietic and stromal progenitors contained within the CD34+ fraction of bone marrow cells formed mixed hematopoietic/stromal cell cultures that maintained the viability of the hematopoietic progenitor cells for 3 weeks in the absence of added hematopoietic cytokines. We characterized some of the hematopoietic cytokines synthesized by stromal cultures derived from either CD34+ or CD34- bone marrow cells using reverse transcriptase-polymerase chain reaction (RT-PCR) amplification of interleukin-3 (IL-3), stem cell factor (SCF), CD34, Flt3/Flk2 ligand (FL), and thrombopoietin (TPO) mRNA sequences. We found ubiquitous expression of TPO mRNA in greater than 90% of stromal cultures initiated by either CD34+ or CD34- cells, and variable expression of SCF, FL, and CD34 mRNA. In particular, SCF and CD34 mRNA were detected only in stromal cultures initiated by CD34+ bone marrow cells, although the differences between CD34+ and CD34- stromal cells were not statistically significant. IL-3 mRNA was not found in any stromal cultures. An enzyme-linked immunosorbent assay (ELISA) of soluble SCF and TPO present in culture supernatants demonstrated that biologically significant amounts of protein were secreted by some cultured stromal cells: eight of 16 samples of conditioned media from stromal cultures initiated by fetal and adult bone marrow contained more than 32 pg/mL SCF (in the linear range of the ELISA), with a median value of 32 pg/mL (range, 9 to 230), while 13 of 24 samples of conditioned media had more than 16 pg/mL TPO (in the linear range of the ELISA), with a median of 37 pg/mL (range, 16 to 106). Our data indicate that stromal cultures initiated by single bone marrow cells can make FL, SCF, and TPO. Local production of early-acting cytokines and TPO by stromal cells may be relevant to the regulation of hematopoietic stem cell self-renewal and megakaryocytopoiesis in the bone marrow microenvironment.

Citing Articles

The Impact of Microenvironment and Dysplasia Types on the Prognosis of Myelodysplastic Syndrome.

Bakkaloglu I, Zemheri I, Kaya A, Kilicaslan E Diagnostics (Basel). 2024; 14(23).

PMID: 39682628 PMC: 11639965. DOI: 10.3390/diagnostics14232720.


Thrombopoietin from hepatocytes promotes hematopoietic stem cell regeneration after myeloablation.

Gao L, Decker M, Chen H, Ding L Elife. 2021; 10.

PMID: 34463253 PMC: 8457823. DOI: 10.7554/eLife.69894.


Mesenchymal stromal cells lower platelet activation and assist in platelet formation in vitro.

Mendelson A, Strat A, Bao W, Rosston P, Fallon G, Ohrn S JCI Insight. 2019; 4(16).

PMID: 31434805 PMC: 6777803. DOI: 10.1172/jci.insight.126982.


Hepatic thrombopoietin is required for bone marrow hematopoietic stem cell maintenance.

Decker M, Leslie J, Liu Q, Ding L Science. 2018; 360(6384):106-110.

PMID: 29622652 PMC: 5930357. DOI: 10.1126/science.aap8861.


Inhibitory Effect of Mesenchymal Stem Cell Co-Culture on Erythroid Differentiation of K562 Cells Compared to The Control Group.

Saleh M, Shamsasanjan K, Movassaghpour A, Akbarzadehlaleh P, Molaeipour Z Cell J. 2017; 19(1):127-136.

PMID: 28367423 PMC: 5241509. DOI: 10.22074/cellj.2016.4133.